Stryker Corporation
SYK · NYSE · Healthcare
$273.40
$0.79 (-0.29%) today
Market Cap
$142.00B
24h Volume
$706.6M
P/E Ratio
42.4
52w High
$385.39
52w Low
$270.01
Est. AI Revenue
15%
7-Day Sparkline (Static)
Company facts
Performance
About Stryker Corporation
Stryker Corporation is a medical device company. It sells orthopedic implants, surgical equipment, and hospital technology to health systems worldwide, earning revenue from devices used in surgery and patient care.
Its most visible AI franchise is the Mako surgical robot, which assists surgeons in orthopedic procedures, paired with AI surgical planning software. Behind the scenes, machine learning supports implant design and hospital analytics tools help health systems run operations.
Founded in 1941 and headquartered in Kalamazoo, Michigan, Stryker employs about 56,000 people under CEO Kevin Lobo and trades on the NYSE.
Stryker Corporation in the AI buildout
Stryker sits in the AI Healthcare and Robotics & Automation layers of the buildout. The Mako surgical robot and its AI planning software form a genuine robotics growth franchise, bringing machine assistance into orthopedic operating rooms. But most of Stryker's revenue still comes from conventional implants, surgical equipment, and hospital products, so surgical robotics is a growth vector inside a much larger device business. Supercycle scores its AI exposure at 18 out of 100.
SYK is tracked in AI Healthcare and Robotics & Automation, rated Peripheral on the AI Exposure leaderboard.
By the numbers
52-week range
SYK trades at $273.40, 3% of the way up its 52-week range of $270.01 to $385.39.
Market cap
Market capitalization is $142.00B, with an AI Exposure Score of 18 out of 100.
Valuation vs peers
Its P/E ratio of 42.4 is above the AI Healthcare category median of 29.6.
Market data as of the close on . Prices are end of day, not live.
Frequently asked questions
What does Stryker Corporation do?
Stryker sells orthopedic implants, surgical equipment, and hospital technology to health systems worldwide, earning revenue from medical devices used in surgery and patient care.
How is Stryker exposed to AI?
Its Mako surgical robot and AI planning software form a growing robotics franchise, but most revenue comes from conventional devices. Supercycle scores its AI exposure at 18 out of 100.
What are Stryker's main AI products?
The Mako AI surgical robot, AI surgical planning software, machine learning for implant design, and hospital analytics AI tools.
Who leads Stryker and where is it based?
CEO Kevin Lobo leads Stryker from Kalamazoo, Michigan. Founded in 1941, the company employs about 56,000 people and trades on the NYSE.
Is SYK a pure play AI stock?
No. Stryker is a diversified medical device maker with a growing surgical robotics franchise. Its Supercycle AI Exposure Score is 18 out of 100.
Profile written 2026-08, updated as the business changes. Editorial content, not investment advice.